The 169^th IRDG meeting was held at Pfizer Limited, Sandwich, Kent on Wednesday 19^th June, 2002. The meeting title and theme was: "Is this the end of the road for off-line testing?"

10:00 Registration and Coffee

10:30-11:15 "Welcome and Introduction to the applications of PAT (Process

11:15–12:.00 "Crystallisation Monitoring" David Lee, GlaxoSmithKline.

12:00–12:.45 "Is a generic solution to reaction monitoring possible in the Pharma industry?" Martin Warman, Pfizer Ltd.

12.45 Lunch

13:30-13:40 IRDG Business

13:40–14.25 "Near IR identity testing. Some whys, wheres and hows" Steve Holland, AstraZeneca

14:25–15:10 "Industrial strength near-infrared chemical imaging" Neil Lewis, Spectral Dimensions, MD, USA.

15:10-15:55 "Generic solutions in the Pharma industry. Part 2" Martin Warman, Pfizer Ltd.

15:55 Close and Tea.